SAB Biotherapeutics
SABS
SABS
42 hedge funds and large institutions have $24.5M invested in SAB Biotherapeutics in 2023 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 5 closing their positions.
Holders
42
Holders Change
+8
Holders Change %
+23.53%
% of All Funds
0.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
7
Reduced
3
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
RI
1
RTW Investments
New York
|
$6.31M |
| 2 |
BI
2
BVF Inc
San Francisco,
California
|
$6.31M |
| 3 |
3
Marshall Wace
London,
United Kingdom
|
$3.16M |
| 4 |
SC
4
Sessa Capital
New York
|
$3.15M |
| 5 |
RCM
5
RA Capital Management
Boston,
Massachusetts
|
$1.63M |
